Levofloxacin- versus clarithromocyn-based first line therapy for Helicobacter pylori infection

被引：0
|
作者：
Rispo, Antonio
Di Girolamo, Elena
Cozzolino, Antonio
Taleb, Hamma Lamine Ali
Pasquale, Luigi
机构：
来源：
GASTROENTEROLOGY | 2006年 / 130卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A574 / A574
页数：1
相关论文
共 50 条
  • [1] Levofloxacin- and amoxcillin-based quadruple therapy for the third-line treatment of Helicobacter pylori infection
    Hsu, Ping-I
    Wu, Deng-Chyang
    [J]. GASTROENTEROLOGY, 2008, 134 (04) : A336 - A336
  • [2] Comparison of Levofloxacin- and Moxifloxacin-Based Triple Therapies with Standard Treatment in Eradication of Helicobacter Pylori as First-Line Therapy
    Rakici, Halil
    Ayaz, Teslime
    Akdogan, Remzi Adnan
    Bedir, Recep
    [J]. DIGESTION, 2014, 90 (04) : 261 - 264
  • [3] Levofloxacin in first-line treatment of Helicobacter pylori infection
    Rispo, A.
    Di Girolamo, E.
    Cozzolino, A.
    Bozzi, R.
    Morante, A.
    Pasquale, L.
    [J]. HELICOBACTER, 2007, 12 (04) : 364 - 365
  • [4] ` Clarithromycin versus Levofloxacin Based Triple Drug Therapy as First Line Eradication for Helicobacter pylori Infection-A Randomised Clinical Study
    NANDA, R. A. J. E. S. H. A. M. A. R. N. A. T. H.
    KRISHNAN, K. A. R. T. H. I. K. E. Y. A. N.
    KOTHAGUNDU, V. A. I. B. H. A., VI
    REDDY, C. H. E. G. I. R. E. D. D. Y. M. A. H. I. N. D. R. A. N. A. T. H.
    MATHEW, S. U. N. I. T. H. A. E. L. Z. A.
    CHANDRAN, G. E. E. T. H. I. K. A.
    [J]. JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2022, 16 (06) : OC26 - OC29
  • [5] The comparison of levofloxacin- and clarithromycin-based bismuth quadruple therapy regimens in Helicobacter pylori eradication
    Arj, Abbas
    Mollaei, Marzieh
    Razavizadeh, Mohsen
    Moraveji, Alireza
    [J]. JOURNAL OF RESEARCH IN PHARMACY PRACTICE, 2020, 9 (02) : 101 - 105
  • [6] First-line triple therapy with levofloxacin for Helicobacter pylori eradication
    Gisbert, J. P.
    Fernandez Bermejo, M.
    Molina Infante, J.
    Perez Gallardo, B.
    Prieto Bermejo, A.
    Mateos Rodriguez, J.
    Robledo Andres, P.
    Gonzalez Garcia, G.
    [J]. HELICOBACTER, 2007, 12 (04) : 432 - 432
  • [7] First-line triple therapy with levofloxacin for Helicobacter pylori eradication
    Gisbert, J. P.
    Fernandez-Bermejo, M.
    Molina-Infante, J.
    Perez-Gallardo, B.
    Prieto-Bermejo, A.-B.
    Mateos-Rodriguez, J.-M.
    Robledo-Andres, P.
    Gonzalez-Garcia, G.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2007, 26 (03) : 495 - 500
  • [8] Efficacy of standard triple therapy versus Levofloxacin based alternate therapy against Helicobacter pylori infection
    Latif, Shahzad
    Akther, Noreen
    Amjed, Sameen
    Jafar, Junaid
    Saleem, Bushra
    Usman, Muhammad
    Amjad, Tuaha
    Maqsood, Waqas
    Waseem, Humaira
    Ashraf, Naim
    [J]. JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION, 2018, 68 (09) : 1295 - 1299
  • [9] Levofloxacin-based triple therapy in first-line treatment for Helicobacter pylori eradication
    Nista, Enrico C.
    Candelli, Marcello
    Zocco, Maria A.
    Cremonini, Filippo
    Ojetti, Veronica
    Finizio, Rosalba
    Spada, Cristiano
    Cammarota, Giovanni
    Gasbarrini, Giovanni
    Gasbarrini, Antonio
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2006, 101 (09): : 1985 - 1990
  • [10] Levofloxacin based triple therapy for third line Helicobacter pylori eradication
    Lee, M.
    Kim, G.
    Lee, B.
    Song, G.
    Park, S.
    Park, S.
    Park, J.
    Kim, S.
    [J]. HELICOBACTER, 2018, 23
12345